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Abstracts / International Journal of Surgery 8 (2010) 501–578530gastrointestinal stomas). The most commonwas minor retraction. Highest
risk were elective patients (56%), those with colostomies (60%) and end
stomas (53%). The complication rate varied between hospitals (9–27%) and
between surgeons.
Conclusions: Across the region, the early complication rate has fallen
from 23.5% to 16%. The rapid presentation of these complications catego-
rises them as surgical failures and reminds us that stoma formation
requires meticulous technique.USE OF NOVEL COLORECTAL ANASTOMOSIS LEAK TESTERS TO ASSESS
THE INTEGRITY OF LEFT-SIDED COLORECTAL ANASTOMOSES
R. Aslam, J.M. Gilbert. Wexham Park Hospital
Aims: Intraoperative testing of left sided colorectal anastomoses has been
shown to be an effective measure to reduce the rate of postoperative
anastomotic leaks. We aim to show our experience using novel Colorectal
Anastomosis Leak Testers.
Methods: A prospective study was conducted on 19 consecutive patients
having left-sided colorectal anastomoses. The Anastomosis Leak Tester-
OP was used when the anastomosis was tested under atmospheric
conditions (open). The Anastomosis Leak Tester-LP was used when the
anastomosis was tested laparoscopically. The anastomoses were also
tested using a methylene blue/manometer method. Outcome measures
included intraoperative leak rates, clinical and radiological anastomotic
leak rate.
Results: The Anastomosis Leak Tester-OP detected no leaks intra-
operatively in 11 open cases. The Anastomosis Leak Tester-LP detected one
leak in 8 cases where the anastomoses were tested laparoscopically.
Overall, the Colorectal Anastomosis Leak Testers detected leaks in one of 19
patients (5%). The methylene blue/manometer method detected no
intraoperative leaks in 19 patients. The postoperative leak rate was 10.5%2.
Conclusions: The Colorectal Anastomosis Leak Testers appear to be
promising tools for the intraoperative detection of anastomotic leaks.
Defunctioning and the risks of a further procedure can be avoided in the
majority of patients by routine intraoperative leak testing.EVALUATION OF THE RESULTS OF LAPAROSCOPIC REPAIR OF VENTRAL
AND INCISIONAL HERNIAS AT A DISTRICT GENERAL HOSPITAL
Khurram Siddique, G.D. Dabare, P.S. Basnyat, S. Basu. William Harvey
Hospital
Aim: Purpose of this study was to evaluate the feasibility, safety and
outcome of laparoscopic reapir at a district general hospital (DGH).
Methods: Data of 45 patients who underwent laparoscopic repair of
abdominal hernias, between September 2007 and December 2009 were
reviewed. Patient demographics, BMI, detailed operative procedure
including outcome was recorded in a proforma and analysed.
Results: Study included 42 (93%) incisional and 3 (7%) ventral hernias. 27
(60%) were female and 18 male with an age of 59* (29–86) and BMI of 32*
(22–44). Incisional included 29 midline and 13 lateral hernias. Of the 45,13
(29%) had single and 32 (71%) multiple defects with an overall size of 111*
(8–400) cm2. Operative timewas 99* (50–240)minutes with amesh size of
366*(100–887) cm2. There were no intra-operative complications. One
procedure was converted in a Crohn's patient due to dense adhesions.
Inpatient stay was 2* (1–6) days and 24 (53%) had only an overnight stay.
Follow up was 12*(3–26) months. Complications include 5 (11%) seromasand 2 (4%) wound infections. All were managed conservatively. 2(4%)
patients recurred requiring open repairs.
Conclusion: Our early experience conﬁrms that laparoscopic repair of
abdominal hernias in a DGH is feasible and safe with promising results.SHOULD MAGNESIUM LEVELS BE MEASURED PRE-OESOPHAGECTOMY?
R. Jones, M. Seenath, M. Hallissey. The Queen Elizabeth Hospital,
Birmingham
Cisplatin Chemotherapy is known to lower serum magnesium levels and
hypomagnesemia predisposes to electrical instability and cardiac
arrhythmias. A review of the last one hundred and nine (109) patients who
underwent oesophagectomy at The Queen Elizabeth Hospital from the
January 2007 to November 2009 was performed. The aim of the study was
to determine whether we should be measuring magnesium levels pre-
oesophagectomy. Sixty-nine percent (69%) of these patients received
cisplatin based neo-adjuvant chemotherapy. The audit revealed that 7.34%
of patients had magnesium levels measured in the month prior to surgery
and of those 50% of the measurements were not requested by surgeons
but, in fact by other specialities. 67.89% of patients were hypomagnesemic
post-oesophagectomy and 33.94% of patients went on to have cardiac
arrhythmias, the most common being atrial ﬁbrillation. Of these 10.81%
were secondary to a leak while the remaining 89.19% were not. 78.9% of
patients received magnesium therapy. As of 16/09/2009 the measurement
of magnesium levels during pre-operative screening was introduced. All
patients with magnesium levels under 0.8mmol/L went on to have hypo-
magnesemia post-operatively, and required treatment with 3 out of 7
developing arrhythmias.WHY ARE WE WAITING? A STUDY OF FACTORS CONTRIBUTING TO
DELAYED TREATMENT OF OESOPHAGOGASTRIC CANCER
J.E.C. Laird, W.L. Craig, A. Tamijmarane, R.P. Coggins. Raigmore Hospital,
Inverness
Background: The impact of Cancer Tracking on compliance with 62 day
treatment targets for oesophagogastric cancer has previously been audi-
ted. Despite a reduction in overall treatment times, a disappointing
number of patients are waiting for prolonged periods.
Aims: To identify potential weaknesses in the cancer pathway contrib-
uting to delay.
Methods: Consecutive diagnoses of oesophago-gastric carcinoma treated
between April 2005–May 2006 (group 1) and January 2007–September
2008 (group 2) were identiﬁed retrospectively. Study periods were chosen
to allow comparison of the service before and after institution of a Cancer
Tracking Service. Signiﬁcant time points in the pathway were extracted by
casenote review.
Results: Median time from referral to ﬁrst treatment fell from 79 to 56
days (p ¼ 0.003). 14 patients (19.2%) in group 1 and 9 in group 2 (9.4%)
waited >100days to commence treatment. Cause of delay was multi-
factorial and affected all areas of the pathway.
Conclusions: The pathway can be seen to operate more efﬁciently in the
later study group. A signiﬁcant number of patients experienced excessive
delay in receiving ﬁrst treatment. Delays occurred at all stages of the
treatment pathway. This audit demonstrates the need for a standardised
pathway for the diagnosis and assessment of patients with oesophago-
gastric cancer.
